Finance

Beta
Lists
MANE:NYSE
Veradermics Inc
$122.94
-0.52%
(-0.64) 1D
$122.94
0.00% (0.00)
After hours
Closed: Jun 30, 4:00:03 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MANE...
Open
$120.00
High
$126.76
Low
$120.00
Mkt. cap
5.14B
Avg. vol.
653.07K
Volume
608.75K
52-wk high
$128.24
52-wk low
$32.00
EPS
-$3.28
No. of employees
24
Open
$120.00
High
$126.76
Low
$120.00
Mkt. cap
5.14B
Avg. vol.
653.07K
Volume
608.75K
52-wk high
$128.24
52-wk low
$32.00
EPS
-$3.28
No. of employees
24
News stories
From sources across the web
About Veradermics Inc
CEO-
Employees24
Founded2019
HeadquartersNew Haven, Connecticut, United States
SectorPharmaceutical industry
Websiteveradermics.com
Analyst ratings
Based on 4 analysts giving stock ratings to MANE in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for MANE in the last 3 months.
Highest
Current $122.94
$138.00 (+12.25%)
Average
$136.00 (+10.62%)
Lowest
$135.00 (+9.81%)
Analyst
Recommendation
Action
Price target
Projected
Date
Geoff Meacham
Citi
Buy
Reiterated
$135.00
+9.8%
06/22/2026
Roger Song
Jefferies
Buy
Maintained
$138.00
+12.2%
06/16/2026
Rami Katkhuda
LifeSci Capital
Buy
Initiated
$135.00
+9.8%
06/16/2026
Serge Belanger
Needham
Buy
Initiated
$136.00
+10.6%
06/02/2026
Marc Goodman
Leerink Partners
Buy
Initiated
$75.00
-39%
03/02/2026
Prakhar Agrawal
Cantor Fitzgerald
Buy
Initiated
-
-
03/01/2026
Last report
May 12, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$1.32 / -$0.85
-55.29%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Dec 2024
Mar 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.95M
11.45M
18.19M
20.92M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.02M
1.47M
4.82M
8.94M
Operating expense
5.97M
12.92M
23.01M
29.86M
Total operating expenses
5.97M
12.92M
23.01M
29.86M
Operating income
-5.97M
-12.92M
-23.01M
-29.86M
Other non operating income
394.00K
33.00K
258.00K
149.00K
EBT including unusual items
-5.66M
-12.40M
-21.85M
-27.23M
EBT excluding unusual items
-5.66M
-12.40M
-21.85M
-27.23M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-5.66M
-12.40M
-21.85M
-27.23M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-1.32
Interest and investment income
209.00K
482.00K
906.00K
2.48M
Interest expense
-292.00K
-
-
-
Net interest expenses
-83.00K
482.00K
906.00K
2.48M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer